Skip to main content
Top
Published in: Inflammation Research 4/2016

01-04-2016 | Short Communication

HDAC9, TWIST1 and FERD3L gene expression in asymptomatic stable and unstable carotid plaques

Authors: Silvia Ferronato, Matteo Gelati, Alberto Scuro, Silvia Olivato, Giovanni Malerba, Maria Grazia Romanelli, Macarena Gomez-Lira, Carlo Setacci

Published in: Inflammation Research | Issue 4/2016

Login to get access

Abstract

Background and objectives

A variant located at the end of HDAC9 gene within clusters of DNAse I sensitivity zones and histone modification hotspots has been associated with large vessel stroke and could be linked to plaque instability. The aim of the study is to define if an altered expression of HDAC9, TWIST1 and FERD3L genes could be involved in plaque vulnerability.

Methods

Histological classification and gene expression analysis were performed in 6 stable and 16 unstable plaques obtained from asymptomatic patients undergoing endarterectomy. Gene expression was analysed by real-time PCR.

Results and conclusions

TWIST1 gene expression resulted higher in stable plaques (P < 0.02). HDAC9 gene expression followed a similar trend (P = 0.11). These results highlighting the significant correlation between TWIST and HDAC9 gene expression suggest that both genes may contribute to plaque stability in a coordinated way.
Appendix
Available only for authorised users
Literature
1.
go back to reference Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951–62.CrossRefPubMedPubMedCentral Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951–62.CrossRefPubMedPubMedCentral
2.
go back to reference Markus HS, Mäkelä KM, Bevan S, Raitoharju E, Oksala N, Bis JC, et al. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke. 2013;44:1220–5.CrossRefPubMedPubMedCentral Markus HS, Mäkelä KM, Bevan S, Raitoharju E, Oksala N, Bis JC, et al. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke. 2013;44:1220–5.CrossRefPubMedPubMedCentral
3.
go back to reference Azghandi S, Prell C, van der Laan SW, Schneider M, Malik R, Berer K, et al. Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1. Stroke. 2015;46:197–202.CrossRefPubMed Azghandi S, Prell C, van der Laan SW, Schneider M, Malik R, Berer K, et al. Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1. Stroke. 2015;46:197–202.CrossRefPubMed
4.
go back to reference Ferronato S, Gomez-Lira M, Menegazzi M, Diani E, Olivato S, Sartori M, et al. Polymorphism -2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients. J Hum Genet. 2013;58:812–4.CrossRefPubMed Ferronato S, Gomez-Lira M, Menegazzi M, Diani E, Olivato S, Sartori M, et al. Polymorphism -2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients. J Hum Genet. 2013;58:812–4.CrossRefPubMed
5.
go back to reference Ferronato S, Lira MG, Olivato S, Scuro A, Veraldi GF, Romanelli MG, et al. Upregulated expression of Toll-like receptor 4 in peripheral blood of ischaemic stroke patients correlates with cyclooxygenase 2 expression. Eur J Vasc Endovasc Surg. 2011;41:358–63.CrossRefPubMed Ferronato S, Lira MG, Olivato S, Scuro A, Veraldi GF, Romanelli MG, et al. Upregulated expression of Toll-like receptor 4 in peripheral blood of ischaemic stroke patients correlates with cyclooxygenase 2 expression. Eur J Vasc Endovasc Surg. 2011;41:358–63.CrossRefPubMed
6.
go back to reference Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation. 2004;110:2190–7.CrossRefPubMed Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation. 2004;110:2190–7.CrossRefPubMed
7.
go back to reference Baldan A, Ferronato S, Olivato S, Malerba G, Scuro A, Veraldi GF, et al. Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients. Inflamm Res. 2014;63:851–8.CrossRefPubMed Baldan A, Ferronato S, Olivato S, Malerba G, Scuro A, Veraldi GF, et al. Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients. Inflamm Res. 2014;63:851–8.CrossRefPubMed
8.
go back to reference Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med. 2006;203:1891–901.CrossRefPubMedPubMedCentral Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, et al. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med. 2006;203:1891–901.CrossRefPubMedPubMedCentral
9.
go back to reference Šošić D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell. 2003;112:169–80.CrossRefPubMed Šošić D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell. 2003;112:169–80.CrossRefPubMed
Metadata
Title
HDAC9, TWIST1 and FERD3L gene expression in asymptomatic stable and unstable carotid plaques
Authors
Silvia Ferronato
Matteo Gelati
Alberto Scuro
Silvia Olivato
Giovanni Malerba
Maria Grazia Romanelli
Macarena Gomez-Lira
Carlo Setacci
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 4/2016
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0904-z

Other articles of this Issue 4/2016

Inflammation Research 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.